Position in ALKS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8,811,075
+$6,140,468 QoQ
Shares Held
249,182
+161.1% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $105,409,906 across 15 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
714,561 | $54,199,451 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
91,677 | $12,077,527 | |
| 3 | ALKS |
Alkermes plc.
This page
|
249,182 | $8,811,075 | |
| 4 | VTRS |
Viatris Inc
|
534,364 | $7,219,257 | |
| 5 | ZTS |
Zoetis Inc.
|
54,702 | $6,466,323 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
75,044 | $4,150,683 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
4,679 | $2,774,553 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
243,416 | $2,317,320 |
All Filings in ALKS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,811,075 | 249,182 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,670,607 | 95,447 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $13,270,500 | 442,350 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $8,306,255 | 290,327 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,825,872 | 237,004 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $9,566,323 | 332,626 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $8,537,565 | 305,022 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,299,836 | 261,404 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,246,963 | 267,712 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,668,670 | 132,252 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $3,423,522 | 122,225 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $2,274,383 | 72,664 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $343,692 | 12,192 | Shares | Sole | 2023-04-24 | |
| 2022-09-30 | $1,729,681 | 77,460 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $2,368,334 | 79,501 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $261,968 | 9,957 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $254,185 | 10,928 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $286,626 | 9,294 | Shares | Sole | 2021-11-08 | |
| 2020-12-31 | $240,397 | 12,050 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||